Granite Investment Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-6,985
| Closed | -$243K | – | 284 |
|
|
2020
Q3 | $243K | Hold |
6,985
| – | – | 0.01% | 249 |
|
|
2020
Q2 | $217K | Sell |
6,985
-5,738
| -45% | -$195K | 0.01% | 249 |
|
|
2020
Q1 | $394K | Sell |
12,723
-2,537
| -17% | -$86.4K | 0.03% | 241 |
|
|
2019
Q4 | $567K | Hold |
15,260
| – | – | 0.03% | 240 |
|
|
2019
Q3 | $520K | Hold |
15,260
| – | – | 0.03% | 267 |
|
|
2019
Q2 | $627K | Sell |
15,260
-2,865
| -16% | -$114K | 0.03% | 254 |
|
|
2019
Q1 | $730K | Sell |
18,125
-439
| -2% | -$17.6K | 0.04% | 269 |
|
|
2018
Q4 | $769K | Buy |
18,564
+439
| +2% | +$18.2K | 0.06% | 196 |
|
|
2018
Q3 | $758K | Sell |
18,125
-933
| -5% | -$35.9K | 0.04% | 204 |
|
|
2018
Q2 | $656K | Sell |
19,058
-2,494
| -12% | -$85.2K | 0.04% | 207 |
|
|
2018
Q1 | $726K | Hold |
21,552
| – | – | 0.05% | 190 |
|
|
2017
Q4 | $741K | Buy |
21,552
+614
| +3% | +$20.9K | 0.05% | 253 |
|
|
2017
Q3 | $709K | Buy |
20,938
+10,242
| +96% | +$329K | 0.04% | 248 |
|
|
2017
Q2 | $341K | Sell |
10,696
-10,821
| -50% | -$341K | 0.02% | 284 |
|
|
2017
Q1 | $698K | Buy |
21,517
+895
| +4% | +$28.2K | 0.05% | 258 |
|
|
2016
Q4 | $635K | Buy |
20,622
+10,870
| +111% | +$332K | 0.05% | 266 |
|
|
2016
Q3 | $313K | Hold |
9,752
| – | – | 0.02% | 288 |
|
|
2016
Q2 | $326K | Sell |
9,752
-2,509
| -20% | -$80.1K | 0.03% | 285 |
|
|
2016
Q1 | $345K | Hold |
12,261
| – | – | 0.03% | 282 |
|
|
2015
Q4 | $376K | Sell |
12,261
-98
| -0.8% | -$3.08K | 0.03% | 279 |
|
|
2015
Q3 | $368K | Hold |
12,359
| – | – | 0.04% | 271 |
|
|
2015
Q2 | $393K | Buy |
12,359
+2,509
| +25% | +$81.8K | 0.04% | 276 |
|
|
2015
Q1 | $325K | Hold |
9,850
| – | – | 0.03% | 275 |
|
|
2014
Q4 | $291K | Sell |
9,850
-1,054
| -10% | -$30.2K | 0.03% | 286 |
|
|
2014
Q3 | $306K | Hold |
10,904
| – | – | 0.04% | 259 |
|
|
2014
Q2 | $307K | Sell |
10,904
-3,689
| -25% | -$105K | 0.04% | 268 |
|
|
2014
Q1 | $445K | Hold |
14,593
| – | – | 0.07% | 177 |
|
|
2013
Q4 | $424K | Hold |
14,593
| – | – | 0.07% | 202 |
|
|
2013
Q3 | $398K | Sell |
14,593
-527
| -3% | -$14.3K | 0.06% | 194 |
|
|
2013
Q2 | $402K | Buy |
+15,120
| New | +$418K | 0.07% | 176 |
|
Other funds holding PFE
Granite Investment Partners's PFE Position: Q4 2020 in Review
Granite Investment Partners sold out of Pfizer (PFE) in Q4 2020, closing a stake of 6,985 shares — an estimated $243K sold.
Granite Investment Partners first reported a position in PFE in Q2 2013 and held it in 30 quarters. The position peaked at $769K in Q4 2018. 2,676 funds tracked by Wall St. Rank hold PFE as of Q4 2020.
- Granite Investment Partners reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
- Granite Investment Partners sold 6,985 Pfizer shares in Q4 2020, an estimated $243K.
- Granite Investment Partners first reported a position in Pfizer in Q2 2013 and held it in 30 quarters.
- Granite Investment Partners's Pfizer position peaked at $769K in Q4 2018.
- 2,676 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.
Based on Granite Investment Partners's 13F filing for Q4 2020, filed 12 Feb 2021.